UTMD
UTMD
NASDAQ · Health Care

Utah Medical Products Inc

$74.49
+0.31 (+0.42%)
As of Sep 28, 10:15 PM ET ·
Financial Highlights (FY 2026)
Revenue
37.70M
Net Income
11.04M
Gross Margin
57.1%
Profit Margin
29.3%
Rev Growth
-9.7%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 57.1% 57.1% 48.9% 48.9%
Operating Margin 29.6% 26.6% 11.5% 10.7%
Profit Margin 29.3% 27.8% 10.8% 9.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 37.70M 41.74M 91.03M 78.58M
Gross Profit 21.53M 23.84M 44.52M 38.43M
Operating Income 11.16M 11.12M 10.51M 8.39M
Net Income 11.04M 11.01M 9.79M 7.70M
Gross Margin 57.1% 57.1% 48.9% 48.9%
Operating Margin 29.6% 26.6% 11.5% 10.7%
Profit Margin 29.3% 27.8% 10.8% 9.8%
Rev Growth -9.7% -9.7% +19.7% +6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 56.05M 53.25M
Total Equity — — 101.18M 111.70M
D/E Ratio — — 0.55 0.48
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 13.21M 13.89M 14.55M 11.68M
Free Cash Flow — — 8.08M 6.39M